• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低 N:P 比的低相对分子质量壳聚糖纳米粒系统用于非毒性多核苷酸递释。

Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.

机构信息

Institute of Biomedical Engineering, Department of Chemical Engineering, École Polytechnique, Montréal, QC, Canada.

出版信息

Int J Nanomedicine. 2012;7:1399-414. doi: 10.2147/IJN.S26571. Epub 2012 Mar 13.

DOI:10.2147/IJN.S26571
PMID:22457597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3310411/
Abstract

Chitosan, a natural polymer, is a promising system for the therapeutic delivery of both plasmid DNA and synthetic small interfering RNA. Reports attempting to identify the optimal parameters of chitosan for synthetic small interfering RNA delivery were inconclusive with high molecular weight at high amine-to-phosphate (N:P) ratios apparently required for efficient transfection. Here we show, for the first time, that low molecular weight chitosan (LMW-CS) formulations at low N:P ratios are suitable for the in vitro delivery of small interfering RNA. LMW-CS nanoparticles at low N:P ratios were positively charged (ζ-potential ~20 mV) with an average size below 100 nm as demonstrated by dynamic light scattering and environmental scanning electron microscopy, respectively. Nanoparticles were spherical, a shape promoting decreased cytotoxicity and enhanced cellular uptake. Nanoparticle stability was effective for at least 20 hours at N:P ratios above two in a slightly acidic pH of 6.5. At a higher basic pH of 8, these nanoparticles were unravelled due to chitosan neutralization, exposing their polynucleotide cargo. Cellular uptake ranged from 50% to 95% in six different cell lines as measured by cytometry. Increasing chitosan molecular weight improved nanoparticle stability as well as the ability of nanoparticles to protect the oligonucleotide cargo from nucleases at supraphysiological concentrations. The highest knockdown efficiency was obtained with the specific formulation 92-10-5 that combines sufficient nuclease protection with effective intracellular release. This system attained >70% knockdown of the messenger RNA, similar to commercially available lipoplexes, without apparent cytotoxicity. Contrary to previous reports, our data demonstrate that LMW-CS at low N:P ratios are efficient and nontoxic polynucleotide delivery systems capable of transfecting a plethora of cell lines.

摘要

壳聚糖是一种天然聚合物,是治疗性递送达质粒 DNA 和合成小干扰 RNA 的有前途的系统。试图确定壳聚糖用于合成小干扰 RNA 递送的最佳参数的报告尚无定论,高相对分子质量和高胺-磷(N:P)比显然是有效转染所必需的。在这里,我们首次表明,低相对分子质量壳聚糖(LMW-CS)制剂在低 N:P 比下适合小干扰 RNA 的体外递送。通过动态光散射和环境扫描电子显微镜分别证明,低 N:P 比的 LMW-CS 纳米粒带正电荷(ζ-电位约 20 mV),平均粒径小于 100nm。纳米粒呈球形,这种形状可降低细胞毒性并增强细胞摄取。纳米粒的稳定性在 N:P 比高于 2 时在略酸性 pH 值为 6.5 的情况下至少有效 20 小时。在较高的碱性 pH 值 8 下,由于壳聚糖中和,这些纳米粒被展开,暴露出其多核苷酸货物。通过细胞计数测量,在六种不同的细胞系中,细胞摄取率在 50%至 95%之间。增加壳聚糖的相对分子质量可提高纳米粒的稳定性,以及纳米粒保护寡核苷酸货物免受核酸酶在高于生理浓度的能力。具有足够的核酸酶保护和有效的细胞内释放的特定制剂 92-10-5 获得了最高的敲低效率。该系统获得了>70%的信使 RNA 敲低,与市售的脂质体类似,没有明显的细胞毒性。与先前的报告相反,我们的数据表明,低 N:P 比的 LMW-CS 是有效的、无毒的多核苷酸递送系统,能够转染多种细胞系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/700c522f8aa8/ijn-7-1399f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/8a2392c04e58/ijn-7-1399f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/eb0cd31041d4/ijn-7-1399f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/d899960ee796/ijn-7-1399f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/1ea50e371c32/ijn-7-1399f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/cc1fcad880b0/ijn-7-1399f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/2b3a81c6d768/ijn-7-1399f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/fdc295362f7b/ijn-7-1399f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/700c522f8aa8/ijn-7-1399f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/8a2392c04e58/ijn-7-1399f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/eb0cd31041d4/ijn-7-1399f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/d899960ee796/ijn-7-1399f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/1ea50e371c32/ijn-7-1399f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/cc1fcad880b0/ijn-7-1399f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/2b3a81c6d768/ijn-7-1399f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/fdc295362f7b/ijn-7-1399f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f0/3310411/700c522f8aa8/ijn-7-1399f8.jpg

相似文献

1
Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.低 N:P 比的低相对分子质量壳聚糖纳米粒系统用于非毒性多核苷酸递释。
Int J Nanomedicine. 2012;7:1399-414. doi: 10.2147/IJN.S26571. Epub 2012 Mar 13.
2
siRNA Delivery with Chitosan: Influence of Chitosan Molecular Weight, Degree of Deacetylation, and Amine to Phosphate Ratio on in Vitro Silencing Efficiency, Hemocompatibility, Biodistribution, and in Vivo Efficacy.壳聚糖介导的 siRNA 递送:壳聚糖分子量、脱乙酰度和胺基与磷酸酯比值对体外沉默效率、血液相容性、生物分布和体内疗效的影响。
Biomacromolecules. 2018 Jan 8;19(1):112-131. doi: 10.1021/acs.biomac.7b01297. Epub 2017 Dec 28.
3
Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.新型透明质酸-壳聚糖纳米粒作为靶向骨关节炎的非病毒基因传递载体。
Int J Pharm. 2011 Nov 28;420(2):358-65. doi: 10.1016/j.ijpharm.2011.08.046. Epub 2011 Sep 3.
4
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.壳聚糖-PEG-TAT 纳米粒的制备及用于 siRNA 的细胞内递送。
Int J Nanomedicine. 2013;8:2041-52. doi: 10.2147/IJN.S43683. Epub 2013 May 21.
5
Lipoplexes versus nanoparticles: pDNA/siRNA delivery.脂质体与纳米颗粒:pDNA/siRNA 递药系统
Drug Deliv. 2013 Feb;20(2):57-64. doi: 10.3109/10717544.2012.752419.
6
Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.用于通过血脑屏障靶向递送 siRNA 的抗体修饰壳聚糖纳米粒的开发,作为抑制星形胶质细胞中 HIV 复制的策略。
Drug Deliv Transl Res. 2017 Aug;7(4):497-506. doi: 10.1007/s13346-017-0368-5.
7
Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.壳聚糖修饰的聚(D,L-乳酸-共-乙醇酸)纳米球用于质粒 DNA 递送和 HBV 基因沉默。
Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.
8
Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.基于壳聚糖的纳米颗粒用于在乳腺癌治疗中靶向递送生存素小干扰RNA并防止其转移。
Int J Nanomedicine. 2016 Sep 27;11:4931-4945. doi: 10.2147/IJN.S105427. eCollection 2016.
9
Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.壳聚糖/siRNA 复合物的物理化学性质:分析聚合物/siRNA 相互作用和生物活性。
J Control Release. 2012 Jan 30;157(2):297-304. doi: 10.1016/j.jconrel.2011.08.023. Epub 2011 Aug 22.
10
Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes.壳聚糖基治疗性纳米颗粒用于 2 型糖尿病相关体外细胞系的联合基因治疗和基因沉默。
Eur J Pharm Sci. 2012 Jan 23;45(1-2):138-49. doi: 10.1016/j.ejps.2011.10.029. Epub 2011 Nov 9.

引用本文的文献

1
Chitosan siRNA Nanoparticles Produce Significant Non-Toxic Functional Gene Silencing in Kidney Cortices.壳聚糖小干扰RNA纳米颗粒在肾皮质中产生显著的无毒功能性基因沉默。
Polymers (Basel). 2024 Sep 9;16(17):2547. doi: 10.3390/polym16172547.
2
Chitosan and Its Structural Modifications for siRNA Delivery.用于小干扰RNA递送的壳聚糖及其结构修饰
Adv Pharm Bull. 2023 Mar;13(2):275-282. doi: 10.34172/apb.2023.030. Epub 2022 Jan 8.
3
Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles.姜黄素/壳聚糖包覆绿色银纳米粒子的抗肝纤维化活性。

本文引用的文献

1
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.使用聚乙二醇包被的空间稳定纳米球进行药物的静脉控释给药。
Adv Drug Deliv Rev. 1995 Sep;16(2-3):215-233. doi: 10.1016/0169-409X(95)00026-4.
2
Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes.壳聚糖基治疗性纳米颗粒用于 2 型糖尿病相关体外细胞系的联合基因治疗和基因沉默。
Eur J Pharm Sci. 2012 Jan 23;45(1-2):138-49. doi: 10.1016/j.ejps.2011.10.029. Epub 2011 Nov 9.
3
Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes.
Sci Rep. 2022 Nov 1;12(1):18403. doi: 10.1038/s41598-022-23276-9.
4
Small interfering RNAs based therapies for intracerebral hemorrhage: challenges and progress in drug delivery systems.基于小干扰RNA的脑出血治疗:药物递送系统的挑战与进展
Neural Regen Res. 2022 Aug;17(8):1717-1725. doi: 10.4103/1673-5374.332129.
5
Fundamental and Practical Aspects in the Formulation of Colloidal Polyelectrolyte Complexes of Chitosan and siRNA.在壳聚糖和 siRNA 的胶体聚电解质复合物的配方中基础和实用的方面。
Methods Mol Biol. 2021;2282:297-327. doi: 10.1007/978-1-0716-1298-9_17.
6
Lipid-based gene delivery to macrophage mitochondria for atherosclerosis therapy.基于脂质的基因递送至巨噬细胞线粒体用于动脉粥样硬化治疗。
Pharmacol Res Perspect. 2020 Apr;8(2):e00584. doi: 10.1002/prp2.584.
7
Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives.天然多糖用于 siRNA 递送:基于壳聚糖、透明质酸及其衍生物的纳米载体。
Molecules. 2019 Jul 15;24(14):2570. doi: 10.3390/molecules24142570.
8
Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.精氨酸丰富的聚乙烯亚胺基多聚物介导的小干扰 RNA 递送至转移性和多柔比星耐药乳腺癌细胞的有效性。
J Pharmacol Exp Ther. 2019 Sep;370(3):902-910. doi: 10.1124/jpet.119.256909. Epub 2019 Apr 2.
9
Gene Silencing via PDA/ERK2-siRNA-Mediated Electrospun Fibers for Peritendinous Antiadhesion.通过聚多巴胺/细胞外信号调节激酶2-小干扰RNA介导的电纺纤维实现基因沉默用于腱周抗粘连
Adv Sci (Weinh). 2018 Nov 20;6(2):1801217. doi: 10.1002/advs.201801217. eCollection 2019 Jan 23.
10
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.壳聚糖在癌症药物递送与治疗中的多方面应用
Mar Drugs. 2017 Mar 27;15(4):96. doi: 10.3390/md15040096.
壳聚糖/质粒 DNA 治疗性纳米复合物在 2 型糖尿病动物模型中有效且安全地传递 GLP-1。
Gene Ther. 2011 Aug;18(8):807-16. doi: 10.1038/gt.2011.25. Epub 2011 Mar 17.
4
Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing.基于壳聚糖酶的方法从转染壳聚糖/siRNA 纳米复合物的细胞中分离 RNA,用于基因沉默的实时 RT-PCR。
Int J Nanomedicine. 2010 Aug 9;5:473-81. doi: 10.2147/ijn.s10879.
5
Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes.壳聚糖-pDNA 复合物的细胞内转运和去凝聚动力学。
Mol Ther. 2010 Oct;18(10):1787-95. doi: 10.1038/mt.2010.143. Epub 2010 Jul 13.
6
Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum.低相对分子质量壳聚糖/DNA 复合物介导的基因传递增强:pH 和血清的影响。
Mol Biotechnol. 2010 Oct;46(2):182-96. doi: 10.1007/s12033-010-9286-1.
7
Cationic carriers of genetic material and cell death: a mitochondrial tale.遗传物质的阳离子载体与细胞死亡:一个线粒体的故事
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1203-9. doi: 10.1016/j.bbabio.2010.03.026. Epub 2010 Apr 8.
8
One-step analysis of DNA/chitosan complexes by field-flow fractionation reveals particle size and free chitosan content.场流分离一步分析 DNA/壳聚糖复合物,揭示颗粒大小和游离壳聚糖含量。
Biomacromolecules. 2010 Mar 8;11(3):549-54. doi: 10.1021/bm901345q.
9
Molecular-weight-dependent toxic effects of chitosans on the human keratinocyte cell line HaCaT.壳聚糖分子量依赖性对人角质形成细胞株 HaCaT 的细胞毒性作用。
Skin Pharmacol Physiol. 2010;23(3):164-70. doi: 10.1159/000276996. Epub 2010 Jan 21.
10
Effect of surface properties on nanoparticle-cell interactions.表面特性对纳米颗粒-细胞相互作用的影响。
Small. 2010 Jan;6(1):12-21. doi: 10.1002/smll.200901158.